scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1046113273 |
P356 | DOI | 10.1038/EYE.2011.2 |
P932 | PMC publication ID | 3094220 |
P698 | PubMed publication ID | 21378995 |
P5875 | ResearchGate publication ID | 50290140 |
P50 | author | Patrick Yu-Wai-Man | Q28321954 |
Patrick F. Chinnery | Q67217990 | ||
P2093 | author name string | P G Griffiths | |
A Atawan | |||
M Bailie | |||
P2860 | cites work | OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes | Q24304868 |
Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy | Q24517959 | ||
Multi-system neurological disease is common in patients with OPA1 mutations | Q24619312 | ||
Optical coherence tomography: a window into the mechanisms of multiple sclerosis | Q24655514 | ||
The interpretation of optical coherence tomography images of the retina. | Q30767457 | ||
Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography | Q33384584 | ||
Optical coherence tomography: another useful tool in a neuro-ophthalmologist's armamentarium | Q33495505 | ||
Detection of glaucoma progression with stratus OCT retinal nerve fiber layer, optic nerve head, and macular thickness measurements | Q33509470 | ||
The prevalence and natural history of dominant optic atrophy due to OPA1 mutations | Q33693684 | ||
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis | Q33983613 | ||
Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies | Q34605409 | ||
Proper method for calculating average visual acuity. | Q34742671 | ||
Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy | Q35590374 | ||
Inherited mitochondrial optic neuropathies | Q37098009 | ||
Optical coherence tomography of the retina and optic nerve - a review | Q37429156 | ||
OPA1 functions in mitochondria and dysfunctions in optic nerve. | Q37457225 | ||
A Clinicopathologic Study of Autosomal Dominant Optic Atrophy | Q40727742 | ||
Infliximab in serpiginous choroiditis | Q43267967 | ||
Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. | Q44306523 | ||
Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy | Q45209829 | ||
Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations | Q45209833 | ||
Axonal loss occurs early in dominant optic atrophy | Q46080771 | ||
Stratus OCT in dominant optic atrophy: features differentiating it from glaucoma. | Q46842598 | ||
An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography | Q46868407 | ||
eOPA1: an online database for OPA1 mutations | Q48142349 | ||
Histogenesis of the intravitreal membrane and secondary vitreous in the mouse. | Q50697248 | ||
Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations. | Q51751759 | ||
Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations. | Q53532046 | ||
The natural history of OPA1-related autosomal dominant optic atrophy | Q56582242 | ||
Histopathology of eye, optic nerve and brain in a case of dominant optic atrophy | Q71814832 | ||
Reproducibility of peripapillary retinal nerve fiber thickness measurements with stratus OCT in glaucomatous eyes | Q80811906 | ||
Hereditary optic neuropathies | Q80981275 | ||
P433 | issue | 5 | |
P921 | main subject | retinal ganglion cell | Q927337 |
optic atrophy | Q3629049 | ||
P304 | page(s) | 596-602 | |
P577 | publication date | 2011-03-04 | |
P1433 | published in | Eye | Q10278937 |
P1476 | title | Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations | |
P478 | volume | 25 |
Q28072026 | A neurodegenerative perspective on mitochondrial optic neuropathies |
Q50074079 | Characterization of Charcot-Marie-Tooth optic neuropathy. |
Q91133950 | Clinical utility gene card for: inherited optic neuropathies including next-generation sequencing-based approaches |
Q42286795 | Complex I inhibition in the visual pathway induces disorganization of the node of Ranvier |
Q98943954 | Concurrent OPA1 mutation and chromosome 3q deletion leading to Behr syndrome: a case report |
Q38605002 | Diagnostic genetic testing for patients with bilateral optic neuropathy and comparison of clinical features according to OPA1 mutation status |
Q35928805 | Disorders of the optic nerve in mitochondrial cytopathies: new ideas on pathogenesis and therapeutic targets |
Q38285228 | Disturbed mitochondrial dynamics and neurodegenerative disorders |
Q30459784 | Dominant optic atrophy. |
Q26752831 | Genetic manipulation for inherited neurodegenerative diseases: myth or reality? |
Q40523875 | Genotype-phenotype heterogeneity of ganglion cell and inner plexiform layer deficit in autosomal-dominant optic atrophy |
Q35221288 | Homocysteine-mediated modulation of mitochondrial dynamics in retinal ganglion cells |
Q37625339 | Mitochondrial Dynamics in Retinal Ganglion Cell Axon Regeneration and Growth Cone Guidance |
Q36358765 | Mitochondrial dynamics regulate growth cone motility, guidance, and neurite growth rate in perinatal retinal ganglion cells in vitro. |
Q36439203 | Modeling autosomal dominant optic atrophy using induced pluripotent stem cells and identifying potential therapeutic targets |
Q27009498 | OCT: New perspectives in neuro-ophthalmology |
Q86018970 | Optical coherence tomography shows early loss of the inferior temporal quadrant retinal nerve fiber layer in autosomal dominant optic atrophy |
Q45483589 | Physiological evidence for impairment in autosomal dominant optic atrophy at the pre-ganglion level |
Q43116350 | Reply: Sensorineural hearing loss in OPA1-linked disorders |
Q42739188 | Reply: Spastic paraplegia in ‘dominant optic atrophy plus’ phenotype due to OPA1 mutation |
Q42581056 | SDOCT thickness measurements of various retinal layers in patients with autosomal dominant optic atrophy due to OPA1 mutations |
Q50726746 | Selective retinal ganglion cell loss in familial dysautonomia. |
Q36315354 | Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy |
Q37616208 | The Pattern of Retinal Ganglion Cell Loss in OPA1-Related Autosomal Dominant Optic Atrophy Inferred From Temporal, Spatial, and Chromatic Sensitivity Losses |
Q47677362 | Thickness mapping of individual retinal layers and sectors by Spectralis SD-OCT in Autosomal Dominant Optic Atrophy. |
Q38040328 | Treatment of hereditary optic neuropathies |
Q33595163 | Treatment strategies for inherited optic neuropathies: past, present and future |
Search more.